Á lódáil...
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.
Na minha lista:
| Main Authors: | , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Russo |
| Foilsithe: |
"Consilium Medicum" Publishing house
2013-01-01
|
| Sraith: | Терапевтический архив |
| Ábhair: | |
| Rochtain Ar Líne: | https://ter-arkhiv.ru/0040-3660/article/view/31226 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|